Hemab Therapeutics Holdings, Inc.

COAG · XNAS

CIK 2114044fmd_1TDYZA92XMGQ772BWA6EBF6S18Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods